{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:26:24Z","timestamp":1785486384243,"version":"3.56.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Health Popul Nutr"],"DOI":"10.1186\/s41043-025-01161-1","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:28:30Z","timestamp":1767025710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low discontinuation rate of tirzepatide treatment in Japanese patients with diabetes mellitus; importance of traditional Japanese diet"],"prefix":"10.1186","volume":"44","author":[{"given":"Takahiro","family":"Hiraide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroku","family":"Yagihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoaki","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"1161_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa2107519","volume":"385","author":"JP Fr\u00edas","year":"2021","unstructured":"Fr\u00edas JP, Davies MJ, Rosenstock J, P\u00e9rez Manghi FC, Fern\u00e1ndez Land\u00f3 L, Bergman BK, Liu B, Cui X, Brown K. SURPASS-2 Investigators. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385:503\u201315.","journal-title":"N Engl J Med"},{"key":"1161_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0140-6736(21)01443-4","volume":"398","author":"B Ludvik","year":"2021","unstructured":"Ludvik B, Giorgino F, J\u00f3dar E, Frias JP, Fern\u00e1ndez Land\u00f3 L, Brown K, Bray R, Rodr\u00edguez \u00c1. Once-weekly Tirzepatide versus once-daily insulin degludec as add-on to Metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. Lancet. 2021;398:583\u201398.","journal-title":"Lancet"},{"key":"1161_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/jdi.12146","volume":"5","author":"C Horikawa","year":"2014","unstructured":"Horikawa C, Yoshimura Y, Kamada C, Tanaka S, Tanaka S, Takahashi A, Hanyu O, Araki A, Ito H, Tanaka A, Ohashi Y, Akanuma Y, Yamada N, Sone H. Dietary intake in Japanese patients with type 2 diabetes: analysis from Japan diabetes complications study. J Diabetes Investig. 2014;5:176\u201387.","journal-title":"J Diabetes Investig"},{"key":"1161_CR4","doi-asserted-by":"publisher","first-page":"e001681","DOI":"10.1136\/bmjdrc-2020-001681","volume":"8","author":"ST McClure","year":"2020","unstructured":"McClure ST, Schlechter H, Oh S, White K, Wu B, Pilla SJ, Maruthur NM, Yeh HC, Miller ER, Appel LJ. Dietary intake of adults with and without diabetes: results from NHANES 2013\u20132016. BMJ Open Diabetes Res Care. 2020;8:e001681.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1161_CR5","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2337\/dc22-1710","volume":"46","author":"T Heise","year":"2023","unstructured":"Heise T, DeVries JH, Urva S, Li J, Pratt EJ, Thomas MK, Mather KJ, Karanikas CA, Dunn J, Haupt A, Milicevic Z, Coskun T. Tirzepatide reduces Appetite, energy Intake, and fat mass in people with type 2 diabetes. Diabetes Care. 2023;46:998\u20131004.","journal-title":"Diabetes Care"},{"key":"1161_CR6","doi-asserted-by":"publisher","first-page":"6784","DOI":"10.1111\/dom.70063","volume":"27","author":"SF Kennedy","year":"2025","unstructured":"Kennedy SF, Knights A, Ravussin E, Sanchez-Delgado G, Nishiyama H, Qian HR, Pratt EJ, Milicevic Z, Haupt A, Coskun T, Martin CK. Impact of Tirzepatide treatment on participant-reported food craving and food preference: secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction. Diabetes Obes Metab. 2025;27:6784\u20139.","journal-title":"Diabetes Obes Metab"},{"key":"1161_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/dom.14843","volume":"25","author":"CE Geisler","year":"2023","unstructured":"Geisler CE, Antonellis MP, Trumbauer W, Martin JA, Coskun T, Samms RJ, Hayes MR. Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents. Diabetes Obes Metab. 2023;25:56\u201367.","journal-title":"Diabetes Obes Metab"},{"key":"1161_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0140-6736(21)01324-6","volume":"398","author":"J Rosenstock","year":"2021","unstructured":"Rosenstock J, Wysham C, Fr\u00edas JP, Kaneko S, Lee CJ, Fern\u00e1ndez Land\u00f3 L, Mao H, Cui X, Karanikas CA, Thieu VT. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist Tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet. 2021;398:143\u201355.","journal-title":"Lancet"},{"key":"1161_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11894-025-00995-3","volume":"27","author":"D Bellavance","year":"2025","unstructured":"Bellavance D, Chua S, Mashimo H. Gastrointestinal motility effects of GLP-1 receptor agonists. Curr Gastroenterol Rep. 2025;27:49.","journal-title":"Curr Gastroenterol Rep"},{"key":"1161_CR10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S2468-1253(24)00188-2","volume":"9","author":"RJ Jalleh","year":"2024","unstructured":"Jalleh RJ, Rayner CK, Hausken T, Jones KL, Camilleri M, Horowitz M. Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions. Lancet Gastroenterol Hepatol. 2024;9:957\u201364.","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Journal of Health, Population and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-025-01161-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41043-025-01161-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-025-01161-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:28:30Z","timestamp":1767025710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41043-025-01161-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1161"],"URL":"https:\/\/doi.org\/10.1186\/s41043-025-01161-1","relation":{},"ISSN":["2072-1315"],"issn-type":[{"value":"2072-1315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of HDC atlas clinic, and informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"429"}}